<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:atom="http://www.w3.org/2005/Atom"  xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Ara in English - CDTI]]></title>
    <link><![CDATA[https://en.ara.cat/etiquetes/cdti/]]></link>
    <description><![CDATA[Ara in English - CDTI]]></description>
    <language><![CDATA[es]]></language>
    <ttl>10</ttl>
    <atom:link href="https://en.ara.cat/rss-internal" rel="self" type="application/rss+xml"/>
    <item>
      <title><![CDATA[The Catalan biotech Allox raises 9.4 million to boost its platform]]></title>
      <link><![CDATA[https://en.ara.cat/economy/the-catalan-biotech-allox-raises-9-4-million-to-boost-its-platform_1_5893757.html]]></link>
      <description><![CDATA[<p><img src="https://static1.ara.cat/clip/dbeb1448-33da-4668-846e-d36efd6d5e26_16-9-aspect-ratio_default_0.jpg" /></p><p>The Catalan biotechnology company Allox has closed a funding round of 10.5 million dollars (about 9.4 million euros) led by Asabys, through its fund Sabadell Asabys II. Also participating were the CDTI –the center for technological development of the Ministry of Science, Innovation and Universities– and the Catalan Institute of Finance (ICF), the public financial entity of the Generalitat.</p>]]></description>
      <dc:creator><![CDATA[Xavier Grau del Cerro]]></dc:creator>
      <guid isPermaLink="true"><![CDATA[https://en.ara.cat/economy/the-catalan-biotech-allox-raises-9-4-million-to-boost-its-platform_1_5893757.html]]></guid>
      <pubDate><![CDATA[Thu, 29 Oct 2026 08:31:13 +0000]]></pubDate>
      <media:content url="https://static1.ara.cat/clip/dbeb1448-33da-4668-846e-d36efd6d5e26_16-9-aspect-ratio_default_0.jpg" type="image/jpeg"/>
      <media:title><![CDATA[The founding team of Allox.]]></media:title>
      <media:thumbnail url="https://static1.ara.cat/clip/dbeb1448-33da-4668-846e-d36efd6d5e26_16-9-aspect-ratio_default_0.jpg"/>
      <subtitle><![CDATA[The round has been led by Asabys with participation from the CDTI and the ICF]]></subtitle>
    </item>
    <item>
      <title><![CDATA[Asabys creates a €120M fund for technology transfer]]></title>
      <link><![CDATA[https://en.ara.cat/economy/asabys-creates-120m-fund-for-technology-transfer_1_5742089.html]]></link>
      <description><![CDATA[<p><img src="https://static1.ara.cat/clip/ae9ca9a2-b909-4584-a157-811315c6bf44_16-9-aspect-ratio_default_0.jpg" /></p><p>The manager Asabys Partners, a leading firm in life sciences investment, will launch a new investment fund of up to 120 million euros, primarily aimed at the technological transfer from universities and research centers to create new companies. Asabys has been selected in the Deep Start call, promoted by the Centre for the Development of Industrial Technology and Innovation (CDTI) –of the Spanish government– in collaboration with the European Investment Fund (EIF). </p>]]></description>
      <dc:creator><![CDATA[Xavier Grau del Cerro]]></dc:creator>
      <guid isPermaLink="true"><![CDATA[https://en.ara.cat/economy/asabys-creates-120m-fund-for-technology-transfer_1_5742089.html]]></guid>
      <pubDate><![CDATA[Tue, 19 May 2026 16:21:06 +0000]]></pubDate>
      <media:content url="https://static1.ara.cat/clip/ae9ca9a2-b909-4584-a157-811315c6bf44_16-9-aspect-ratio_default_0.jpg" type="image/jpeg"/>
      <media:title><![CDATA[Josep LLuis Sanfeliu and Clara Campas partners of the health fund Asabys]]></media:title>
      <media:thumbnail url="https://static1.ara.cat/clip/ae9ca9a2-b909-4584-a157-811315c6bf44_16-9-aspect-ratio_default_0.jpg"/>
      <subtitle><![CDATA[The manager has been selected in the call for the European Investment Fund and the CDTI]]></subtitle>
    </item>
  </channel>
</rss>
